FCDA recommendations on cannabis regulation — what the commission actually asks for

Since 2008, the Federal Commission for Drug Issues (FCDA) has recommended a regulated cannabis market. What do the three central position papers say — and what does it mean for the NarcA revision?

TL;DR

  • FCDA has recommended a regulated adult cannabis market since 2008.
  • 2019 position paper: 4-pillar model (prevention, therapy, harm reduction, regulation).
  • 2023 position paper: concrete implementation recommendations to SHK-N.
  • Key points: 18+ age limit, ad ban, earmarked cannabis tax, no blanket home-grow ban.
  • Political weight: FCDA is an explicit reference for the Cannabis sub-committee.

2008 position paper — the foundation

'Cannabis: a status report' — the FCDA established that a prohibitionist model neither reduces consumption nor the black market. First recommendation for a regulated market with youth protection, independent of the 2008 Hemp initiative rejection.

2019 position paper — the 4-pillar model

'Regulate cannabis, because regulation works' — the FCDA expanded Switzerland's defining 4-pillar drug policy model: prevention, therapy, harm reduction and, new, regulation as the fourth pillar.

  • Legal access for adults from age 18
  • State-licensed production and distribution
  • Earmarked cannabis tax financing prevention
  • Advertising ban analogous to tobacco
  • No blanket ban on personal cultivation

2023 position paper — recommendations to SHK-N

The updated position speaks directly to the Cannabis sub-committee: concrete proposals on outlet density, THC disclosure, price/tax mix, pilot-trial evaluation and roadside enforcement.

FAQ

What is the FCDA?

The Federal Commission for Drug Issues is an extra-parliamentary expert commission of the Federal Council, currently 15 members from medicine, law, sociology and practice.

Are FCDA recommendations binding?

No, they are expert recommendations. They carry high political weight and are regularly cited by the Federal Council and Parliament.

Does the FCDA recommend home-grow?

It opposes a blanket ban but does not demand a specific plant count — that is up to the legislator.

What role do pilot trials play for the FCDA?

Central evidence source. The FCDA recommends comprehensive evaluation before legislative decisions.

Where can I find the original documents?

All FCDA position papers are publicly available on the FOPH website under 'Drugs / FCDA'.